Candidate vaccines for Epstein-Barr virus.
作者信息
Moss D J, Suhrbier A, Elliott S L
出版信息
BMJ. 1998 Aug 15;317(7156):423-4. doi: 10.1136/bmj.317.7156.423.
Abstract
摘要
相似文献
1
Candidate vaccines for Epstein-Barr virus.爱泼斯坦-巴尔病毒候选疫苗。
BMJ. 1998 Aug 15;317(7156):423-4. doi: 10.1136/bmj.317.7156.423.
2
[New perspectives in the search for a vaccine against the Epstein-Barr virus].
An Med Interna. 1991 Nov;8(11):527-8.
3
Control of viral disease: the development of Epstein-Barr virus vaccines.
Springer Semin Immunopathol. 1991;13(2):249-62. doi: 10.1007/BF00201472.
4
Strategies involved in developing an effective vaccine for EBV-associated diseases.
Adv Cancer Res. 1996;69:213-45. doi: 10.1016/s0065-230x(08)60864-7.
5
Vaccine control of malignancies induced by lymphotropic herpesviruses.
Prog Clin Biol Res. 1983;132B:61-70.
6
7
Epstein-Barr virus infection and depression.
J Clin Psychiatry. 1986 Oct;47(10):529-30.
8
Epstein-barr-virus nuclear antigen.爱泼斯坦-巴尔病毒核抗原
Prog Med Virol. 1982;28:145-79.
9
Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.人类细胞毒性T淋巴细胞对爱泼斯坦-巴尔病毒感染的反应。
Annu Rev Immunol. 1997;15:405-31. doi: 10.1146/annurev.immunol.15.1.405.
10
Epstein-Barr virus (EBV)-antibody profile in an infant congenitally infected by the EBV.
Pediatrics. 1982 Nov;70(5):823-4.
引用本文的文献
1
Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis.基于CD8 + T细胞肽表位的传染性单核细胞增多症疫苗的I期试验。
J Virol. 2008 Feb;82(3):1448-57. doi: 10.1128/JVI.01409-07. Epub 2007 Nov 21.
本文引用的文献
1
Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.通过DNA疫苗递送多种CD8细胞毒性T细胞表位
J Immunol. 1998 Feb 15;160(4):1717-23.
2
Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.人类细胞毒性T淋巴细胞对爱泼斯坦-巴尔病毒感染的反应。
Annu Rev Immunol. 1997;15:405-31. doi: 10.1146/annurev.immunol.15.1.405.
3
Immunisation of common marmosets with vaccinia virus expressing Epstein-Barr virus (EBV) gp340 and challenge with EBV.用表达爱泼斯坦-巴尔病毒（EBV）gp340的痘苗病毒免疫普通狨猴，并使其感染EBV。
J Med Virol. 1996 Nov;50(3):263-71. doi: 10.1002/(SICI)1096-9071(199611)50:3<263::AID-JMV9>3.0.CO;2-7.
4
Strategies involved in developing an effective vaccine for EBV-associated diseases.
Adv Cancer Res. 1996;69:213-45. doi: 10.1016/s0065-230x(08)60864-7.
5
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.使用基因修饰的病毒特异性T淋巴细胞来控制爱泼斯坦-巴尔病毒相关的淋巴增殖。
Lancet. 1995 Jan 7;345(8941):9-13. doi: 10.1016/s0140-6736(95)91150-2.
6
First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen.
Dev Biol Stand. 1995;84:171-7.
7
Epstein-Barr virus-associated lymphoproliferative disorders in immunocompromised individuals.
Adv Cancer Res. 1991;57:329-80. doi: 10.1016/s0065-230x(08)61003-9.
8
Epstein-Barr virus vaccines.
Vaccine. 1992;10(9):563-71. doi: 10.1016/0264-410x(92)90434-l.
Zotero 插件